Klin Monbl Augenheilkd 2014; 231(5): 512-517
DOI: 10.1055/s-0034-1368396
Übersicht
Georg Thieme Verlag KG Stuttgart · New York

Atopische Keratokonjunktivitis

Atopic Keratoconjunctivitis
B. Sobolewska
Universitäts-Augenklinik, Eberhard-Karls Universität, Tübingen
,
M. Zierhut
Universitäts-Augenklinik, Eberhard-Karls Universität, Tübingen
› Author Affiliations
Further Information

Publication History

eingereicht 05 March 2014

akzeptiert 13 March 2014

Publication Date:
05 May 2014 (online)

Zusammenfassung

Es hat sich bewährt, die atopische Keratokonjunktivitis als eine nicht infektiöse entzündliche Augenerkrankung, die mit einer Atopie vergesellschaftet ist, zu definieren. Die Immunpathogenese wird bisher nicht vollständig verstanden. Die Diagnose basiert auf einer gezielten Anamnese und der klinischen Manifestation. Die Erkrankung kann einen überaus schwerwiegenden Verlauf nehmen. Daher benötigt ein erfolgreiches Management der atopischen Keratokonjunktivitis einen multidisziplinären Ansatz, welcher die Prävention, die dermatologische Betreuung und einen entsprechenden ophthalmologischen Behandlungsalgorithmus umfasst.

Abstract

It is useful to define atopic keratoconjunctivitis (AKC) as a non-infectious inflammatory condition of the ocular surface, which is associated with atopy. The pathogenesis of the disorder is not completely understood. The diagnosis is based on the patientʼs history and the clinical manifestations. Successful management of AKC, which can become a serious condition, requires a multidisciplinary approach that involves prevention, dermatological care and an adequate ophthalmological treatment algorithm.

 
  • Literatur

  • 1 Power WJ, Tugal-Tutkun I, Foster CS. Long-term follow-up of patients with atopic keratoconjunctivitis. Ophthalmology 1998; 105: 637-642
  • 2 Tomida I, Schlote T, Bräuning J et al. Cyclosporin A 2 % eyedrops in therapy of atopic and vernal keratoconjunctivitis. Ophthalmologe 2002; 99: 761-767
  • 3 Hanifin JM. Atopiform dermatitis: do we need another confusing name for atopic dermatitis?. Br J Dermatol 2002; 147: 430-432
  • 4 Hogan MJ. Atopic keratoconjunctivitis. Trans Am Ophthalmol Soc 1952; 50: 265-281
  • 5 Guglielmetti S, Dart JK, Calder V. Atopic keratoconjunctivitis and atopic dermatitis. Curr Opin Allergy Clin Immunol 2010; 10: 478-485
  • 6 Calonge M, Herreras JM. Clinical grading of atopic keratoconjunctivitis. Curr Opin Allergy Clin Immunol 2007; 7: 442-445
  • 7 Foster CS, Calonge M. Atopic keratoconjunctivitis. Ophthalmology 1990; 97: 992-1000
  • 8 Leung DY, Bieber T. Atopic dermatitis. Lancet 2003; 361: 151-160
  • 9 Bieber T. Mechanisms of disease: atopic dermatitis. N Engl J Med 2008; 358: 1483-1494
  • 10 Watson W, Kapur S. Atopic dermatitis. Allergy Asthma Clin Immunol 2011; 7 (Suppl. 01) S4
  • 11 Larsen FS, Hanifin JM. Epidemiology of atopic dermatitis. Immunol Allergy Clin North Am 2002; 22: 1-25
  • 12 Novak N, Bieber T. Pathophysiologie der atopischen Dermatitis: Neue Erkenntnisse und der Nutzen für die Praxis. Dtsch Arztebl 2004; 101: A-108/B-94/C-92
  • 13 Leonardi A, Fregona IA, Plebani M et al. Th1- and Th2-type cytokines in chronic ocular allergy. Graefes Arch Clin Exp Ophthalmol 2006; 244: 1240-1245
  • 14 Uchio E, Ono SY, Ikezawa Z et al. Tear levels of interferon-gamma, interleukin (IL) -2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis. Clin Exp Allergy 2000; 30: 103-139
  • 15 Lampinen M, Carlson M, Håkansson LD et al. Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 2004; 59: 793-805
  • 16 Montan PG, van Hage-Hamsten M. Eosinophil cationic protein in tears in allergic conjunctivitis. Br J Ophthalmol 1996; 80: 556-560
  • 17 Leonardi A, Jose PJ, Zhan H et al. Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis. Ophthalmology 2003; 110: 487-492
  • 18 Brewitt H, Zierhut M. Trockenes Auge: Anatomie, Physiologie, Pathophysiologie, Diagnostik, Therapie. Heidelberg: Kaden; 2001
  • 19 Rachdan D, Anijeet DR, Shah S. Atopic keratoconjunctivitis: present day diagnosis. Br J Ophthalmol 2012; 96: 1361-1362
  • 20 Bielory B, Bielory L. Atopic dermatitis and keratoconjunctivitis. Immunol Allergy Clin North Am 2010; 30: 323-336
  • 21 Sy H, Bielory L. Atopic keratoconjunctivitis. Allergy Asthma Proc 2013; 34: 33-41
  • 22 Tuft SJ, Kemeny DM, Dart JK et al. Clinical features of atopic keratoconjunctivitis. Ophthalmology 1991; 98: 150-158
  • 23 Easty D, Entwistle C, Funk A et al. Herpes simplex keratitis and keratoconus in the atopic patient. A clinical and immunological study. Trans Ophthalmol Soc U K 1975; 95: 267-276
  • 24 Bair B, Dodd J, Heidelberg K et al. Cataracts in atopic dermatitis: a case presentation and review of the literature. Arch Dermatol 2011; 147: 585-588
  • 25 Bawazeer AM, Hodge WG, Lorimer B. Atopy and keratoconus: a multivariate analysis. Br J Ophthalmol 2000; 84: 834-836
  • 26 Rahi A, Davies P, Ruben M et al. Keratoconus and coexisting atopic disease. Br J Ophthalmol 1977; 61: 761-764
  • 27 Yoneda K, Okamoto H, Wada Y et al. Atopic retinal detachment. Report of four cases and a review of the literature. Br J Dermatol 1995; 133: 586-591
  • 28 Takahashi M, Suzuma K, Inaba I et al. Retinal detachment associated with atopic dermatitis. Br J Ophthalmol 1996; 80: 54-57
  • 29 Kallen C, Reinhard T, Schilgen G et al. [Atopic keratoconjunctivitis: probably a risk factor for the development of conjuntival carcinoma]. Ophthalmologe 2003; 100: 808-814
  • 30 Akdis CA, Akdis M, Bieber T et al. European Academy of Allergology and Clinical Immunology/American Academy of Allergy Asthma and Immunology. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol 2006; 118: 152-169
  • 31 Wakamatsu TH, Satake Y, Igarashi A et al. IgE and eosinophil cationic protein (ECP) as markers of severity in the diagnosis of atopic keratoconjunctivitis. Br J Ophthalmol 2012; 96: 581-586
  • 32 Wakamatsu TH, Tanaka M, Satake Y et al. Eosinophilic cationic protein as a marker for assessing the efficacy of tacrolimus ophthalmic solution in the treatment of atopic kertaoconjunctivitis. Mol Vis 2011; 17: 932-938
  • 33 Jun J, Bielory L, Raizman MB. Vernal conjunctivitis. Immunol Allergy Clin North Am 2008; 28: 59-82
  • 34 OʼBrien TP. Allergic conjunctivitis: an update on diagnosis and management. Curr Opin Allergy Clin Immunol 2013; 13: 543-549
  • 35 Bielory L. Ocular allergy overview. Immunol Allergy Clin North Am 2008; 28: 1-23
  • 36 Kari O, Saari KM. Updates in the treatment of ocular allergies. J Asthma Allergy 2010; 3: 149-158
  • 37 Ehlers WH, Donshik PC. Giant papillary conjunctivitis. Curr Opin Allergy Clin Immunol 2008; 8: 445-449
  • 38 Sobolewska B, Zierhut M. Ocular rosacea. Hautarzt 2013; 64: 506-508
  • 39 Sobolewska B, Deuter C, Zierhut M. Current medical treatment of ocular mucous membrane pemphigoid. Ocul Surf 2013; 11: 259-266
  • 40 González-López JJ, López-Alcalde J, Morcillo Laiz R et al. Topical cyclosporine for atopic keratoconjunctivitis. Cochrane Database Syst Rev 2012; (9) CD009078
  • 41 Sakarya Y, Sakarya R. Treatment of refractory atopic blepharoconjunctivitis with topical tacrolimus 0.03 % dermatologic ointment. J Ocul Pharmacol Ther 2012; 28: 94-96
  • 42 García DP, Alperte JI, Cristóbal JA et al. Topical tacrolimus ointment for treatment of intractable atopic keratoconjunctivitis: a case report and review of the literature. Cornea 2011; 30: 462-465
  • 43 Al-Amri AM. Long-term follow-up of tacrolimus ointment for treatment of atopic keratoconjunctivitis. Am J Ophthalmol 2014; 157: 280-286
  • 44 Tzu JH, Utine CA, Stern ME et al. Topical calcineurin inhibitors in the treatment of steroid-dependent atopic keratoconjunctivitis. Cornea 2012; 31: 649-654
  • 45 Cornish KS, Gregory ME, Ramaesh K. Systemic cyclosporin A in severe atopic keratoconjunctivitis. Eur J Ophthalmol 2010; 20: 844-851
  • 46 Akhavan A, Rudikoff D. Atopic dermatitis: systemic immunosuppressive therapy. Semin Cutan Med Surg 2008; 27: 151-155
  • 47 BuBmann C, Bieber T, Novak N. Systemic therapeutic options for severe atopic dermatitis. J Dtsch Dermatol Ges 2009; 7: 205-219
  • 48 Stumpf T, Luqmani N, Sumich P et al. Systemic tacrolimus in the treatment of severe atopic keratoconjunctivitis. Cornea 2006; 25: 1147-1149
  • 49 Takano Y, Fukagawa K, Miyake-Kashima M et al. Dramatic healing of an allergic corneal ulcer persistent for 6 months by amniotic membrane patching in a patient with atopic keratoconjunctivitis: a case report. Cornea 2004; 23: 723-725